Ahmet Alacacıoğlu

Ahmet Alacacıoğlu

İzmir Katip Çelebi University - İzmir / Türkiye
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 190832
İzmir Kâtip Çelebi Üniversitesi
person_outline Ahmet Alacacıoğlu's MOST POPULAR ARTICLES
1-) Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN … The Lancet Oncology 22 (1), 51-65, 2021
2-) Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally … Annals of Oncology 32 (8), 994-1004, 2021
3-) Burnout in nurses and physicians working at an oncology department Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2009
4-) Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? International journal of clinical oncology 20, 70-81, 2015
5-) Quality of life, anxiety, and depression in Turkish colorectal cancer patients Supportive care in cancer 18, 417-421, 2010